SubsidieMeestersVISUALIZACIÓN DE BIOPOTENCIALES PARA EQUIPOS CARDIOLÓGICOS
VR-CARDIO is an innovative medical tool that uses AR/VR for precise visualization and diagnosis of arrhythmia, enhancing cardiac ablation speed and accuracy.
Projectdetails
Introduction
VR-CARDIO is a unique medical tool for visualization and diagnosis of arrhythmia. The arrhythmia is an alteration of the heart rhythm. It occurs when the electrical impulses that coordinate the beats do not work properly.
Functionality
VR-CARDIO allows a reliable and validated estimation of electrocardiogram cardiac and transmembrane action potentials that enable detecting with absolute precision the origin and mechanism of heart disease.
Advantages
Instead of using only electrocardiograms captured by catheters, as is done with current Cardiac Navigation Systems (CNS), VR-CARDIO enables a revolutionary bioelectrical navigation of the cardiac system in a precise and safe way.
Key Benefits:
- It operates in the entire volume of the cardiac cavity.
- It allows the cardiac ablation process to be infinitely faster.
- The electrophysiologist is constantly watching the development of the impulse electric throughout the heart.
Visualization Technology
This is made possible due to its 360º visualization in augmented reality (AR) and/or virtual reality (VR).
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 3.589.741 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 30-6-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SPIKA TECH SLpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
ELEM Virtual Heart Populations for SupercomputersELEMs V.Heart is a supercomputer platform for in-silico clinical trials using digital avatars to evaluate therapy outcomes, enhancing safety, efficacy, and precision medicine while reducing trial risks. | EIC Accelerator | € 2.482.096 | 2023 | Details |
AI-based clinical software for fully automated Cardiac Magnetic Resonance reportingAI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes. | EIC Accelerator | € 1.753.842 | 2022 | Details |
A revolutionary technology platform for providing life-saving treatment for end-stage heart failure patientsreBEAT is an innovative heart support technology that safely assists both sides of the heart, aiming to improve treatment accessibility and cost-effectiveness for end-stage heart failure patients. | EIC Accelerator | € 2.499.999 | 2023 | Details |
The first heart failure therapy management point-of-care device with multiplex and multimodal sensorCardioCap is a handheld POC device that uses a finger-prick blood sample to simultaneously assess heart failure severity through four biomarkers, aiming to reduce re-hospitalization and mortality rates by 30%. | EIC Accelerator | € 2.499.999 | 2025 | Details |
ELEM Virtual Heart Populations for Supercomputers
ELEMs V.Heart is a supercomputer platform for in-silico clinical trials using digital avatars to evaluate therapy outcomes, enhancing safety, efficacy, and precision medicine while reducing trial risks.
AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting
AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.
A revolutionary technology platform for providing life-saving treatment for end-stage heart failure patients
reBEAT is an innovative heart support technology that safely assists both sides of the heart, aiming to improve treatment accessibility and cost-effectiveness for end-stage heart failure patients.
The first heart failure therapy management point-of-care device with multiplex and multimodal sensor
CardioCap is a handheld POC device that uses a finger-prick blood sample to simultaneously assess heart failure severity through four biomarkers, aiming to reduce re-hospitalization and mortality rates by 30%.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Laesy Visualisatie 2.0Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten. | Mkb-innovati... | € 162.190 | 2020 | Details |
CAP.AICAP.AI ontwikkelt een platform dat hartritmes analyseert met AI en machine learning om hartaandoeningen vroegtijdig op te sporen. | 1.1 - Het ve... | € 498.266 | 2022 | Details |
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatmentsThis project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease. | ERC Starting... | € 1.500.000 | 2024 | Details |
Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular DiseasesThe project aims to revolutionize cardiovascular disease diagnosis and treatment by developing a fast, automated cardiac MRI system for comprehensive, one-click imaging and analysis. | ERC Starting... | € 1.498.529 | 2023 | Details |
Using CARDIac simulations to run in-silicO clinical TRIALSThis project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials. | ERC Starting... | € 1.499.423 | 2022 | Details |
Laesy Visualisatie 2.0
Het project Laesie Visualisatie 2.0 ontwikkelt software voor verbeterde visualisatie van hartweefsel, wat leidt tot efficiëntere behandeling van hartritmestoornissen en lagere gezondheidskosten.
CAP.AI
CAP.AI ontwikkelt een platform dat hartritmes analyseert met AI en machine learning om hartaandoeningen vroegtijdig op te sporen.
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments
This project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease.
Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular Diseases
The project aims to revolutionize cardiovascular disease diagnosis and treatment by developing a fast, automated cardiac MRI system for comprehensive, one-click imaging and analysis.
Using CARDIac simulations to run in-silicO clinical TRIALS
This project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials.